Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL

Epilepsy and Behavior

Volumn 48, Issue , 2015, Pages 88-95

  Rahman, Z ^a   Wong, C H ^a,b   Dexter, M ^a,b   Olsson, G ^a,b   Wong, M ^a   Gebsky, V ^c   Nahar, N ^a   Wood, A ^a   Byth, K ^a   King, M ^c   Bleasel, A B ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antiepileptic; Brain tumor related epilepsy; Chemotherapy; Cognition; Health related quality of life; Radiotherapy

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; ANXIETY; ARTICLE; BARTHEL INDEX; BRAIN TUMOR; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; EMOTIONAL WELL BEING; EPILEPSY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOOD; PHYSICAL WELL BEING; PRIMARY TUMOR; QUALITY OF LIFE; RISK FACTOR; SOCIAL INTERACTION; SOCIAL WELL BEING; WELLBEING; AFFECT; AGED; BRAIN NEOPLASMS; COGNITION DISORDERS; COMPLICATION; DAILY LIFE ACTIVITY; NEUROSURGERY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; SEIZURES; SEVERITY OF ILLNESS INDEX; SOCIAL ADAPTATION; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ANXIETY; BRAIN NEOPLASMS; COGNITION; COGNITION DISORDERS; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGERY; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEIZURES; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SURVEYS AND QUESTIONNAIRES;

EID: 84933529663     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.03.016     Document Type: Article

References (50)

1. Olafsson E., Ludvigsson P., Gudmundsson G., Hesdorffer D., Kjartansson O., Hauser W.A. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005, 4:627-634.
2. Bromfield E.B. Epilepsy in patients with brain tumors and other cancers. Rev Neurol Dis 2004, 1(Suppl. 1):27-33.
3. Hauser W.A., Annegers J.F., Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935 -1984. Epilepsia. 1993, 34:453-468.
4. Lund M. Epilepsy in association with intracranial tumor. Acta Neurol Psychiatr Scand 1952, 81(Suppl.):87-106.
5. Penfield W., Erickson T.C., Tarlov I. Relation of intracranial tumors and symptomatic epilepsy. Arch Neurol Psychiatry 1940, 44:300-315.
6. Ketz E. Brain tumors and epilepsy. Handbook of clinical neurology 1974, vol. 16:254-269. North-Holland, Amsterdam.
7. Le Blanc F.E., Rasmussen T. Cerebral seizures and brain tumors. Handbook of clinical neurology 1974, vol. 15:295-301. North-Holland, Amsterdam.
8. Berntsson S.G., Malmer B., Bondy M.L., Qu M., Smits A. Tumor-associated epilepsy and glioma: are there common genetic pathways?. Acta Oncol 2009, 48:955-963.
9. Rasmussen T. Surgery of epilepsy associated with brain tumors. Neurosurgical management of the epilepsies. Advances in neurology, vol. 8 1975, 227-239. Raven Press, New York. D.P. Purpura, J.K. Penry, R.D. Walter (Eds.).
10. Rasmussen T., Blundell J. Epilepsy and brain tumor. Clin Neurosurg 1959, 7:138-158.
11. Daumas-Duport C., Scheithauer B.W., Chodkiewicz J.P., Laws E.R., Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Neurosurgery 1988, 23:545-556.
12. Kornblith P.L., Walker M.D., Cassady J.P. Pathology of central nervous system tumors. Neurologic oncology. Philadelphia: J. B. Lippincott 1987, 35-48. P.L. Kornblith, M.D. Walker, J.R. Cassady (Eds.).
13. Cascino G.D. Epilepsy and brain tumors: implications for treatment. Epilepsia 1990, 31(3 Suppl):37-44.
14. Sperling M.R., Ko J. Seizures and brain tumors. Semin Oncol 2006, 33:333-341.
15. Baker G.A., Jacoby A., Buck D., Stalgis C., Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997, 38:353-362.
16. Meador K.J. Cognitive side effects of medications. Neurol Clin 1998, 16:141-155.
17. Vining E.P. Cognitive dysfunction associated with antiepileptic drug therapy. Epilepsia 1987, 28:S18-S22.
18. Gupta T., Sarin R. Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol. 2002, 3:557-564.
19. Klein M., Engelberts N.H.J., Ploeg H.M.V., Trenité D.G.A.K.N., Aaronson N.K., Taphoorn M.J.B., et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 2003, 54(4):514-520.
20. Weitzner M.A., Meyers C.A., Gelke C.K., Byrne K.S., Cella D.F., Levin V.A. The Functional Assessment of Cancer Therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995, 75:1151-1161.
21. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993, 11:570-579.
22. Cramer J.A., Perrine K., Devinsky O., Bryant-Comstock L., Meador K., Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998, 39(1):81-88.
23. Smith Tasha, Gildeh Nadia, Holmes Clive The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. La Revue canadienne de psychiatrie 2007, 52:329-332.
24. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000, 55(11):1621-1626.
25. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67(6):361-370.
26. Yates J.W., Chalmer B., Mckegney F.P. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer 1980, 45:2220-2224.
27. Brucker P.S., Yost K., Cashy J. Webster K and Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy--General (FACT-G). Eval Health Prof 2005, 28(2):192-211.
28. Cheng J.X., Zhang X., Liu B.L. Health-related quality of life in patients with high-grade glioma. Neuro Oncol 2008, 11(1):41-50.
29. Budrukkar A., Jalali R., Dutta D., Sarin R., Devlekar R., Parab S., Kakde A. Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neuro-Oncol 2009, 95(3):413-419.
30. Dirven L., Neil K.A., Heimans J.J., Taphoorn M.J.B. Health-related quality of life in high-grade glioma patients. Chin J Cancer 2014, 33(1):41-45.
31. Klein M. Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities. Neuro Oncol 2012, 14(Suppl. 4):17-24.
32. Maschio M., Dinapoli L., Sperati F., Pace A., Fabi A., Vidiri A., Muti P. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neuro-Oncol 2011, 104(1):205-214.
33. Waagemans M.L. Long-term impact of cognitive deficits and epilepsy on quality of life in patients with low-grade meningiomas. Neurosurgery 2011, 69:72-79.
34. Guerrini R., Rosati A., Giordano F., Genitori L., Barba C. The medical and surgical treatment of tumoral seizures: current and future perspectives. [Review]. Epilepsia 2013, 54(54 Suppl 9):84-90.
35. Lhatoo S.D., Moghimi N., Schuele S. Tumor-related epilepsy and epilepsy surgery. Epilepsia 2013, 54(Suppl. 9):1-4.
36. Rogers L.R., Morris H.H., Lupica K. Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology. 1993, 43:1599-1601.
37. Ruda R., Trevisan E., Magliola U., Mantovani C., Ricardi U., Soffietti R. Efficacy of radiation therapy on epileptic seizures of grade 2 and 3 gliomas: a retrospective study. J Clin Oncol. 2011, 29:2074.
38. Soffietti R., Baumert B.G., Bello A., von Deimling A., Duffau H., Frénay M., et al. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol. 2010, 17:1124-1133.
39. Mason W., Krol G., De Angelis L.M. Low grade oligodendroglioma responds to chemotherapy. Neurology. 1996, 46:203-207.
40. Soffietti R., Rudà R., Bradac G.B., Schiffer D. PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery. 1998, 43:1066-1073.
41. Brada M., Viviers L., Abson C., Hines F., Britton J., Ashley S., et al. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol. 2003, 14:1715-1721.
42. Pace A., Vidiri A., Galiè E., et al. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol. 2003, 14:1722-1726.
43. Hoang-Xuan K., Capelle L., Kujas M., Taillibert S., Duffau H., Lejeune J., et al. Temozolomide as initial treatments for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1 p deletions. J Clin Oncol. 2004, 22:3133-3138.
44. Frenay M.P., Fontaine D., Vandenbos F., Lebrun C. First-line nitrosourea-based chemotherapy in symptomatic nonresectable supratentorial pure low-grade astrocytomas. Eur J Neurol. 2005, 12:685-690.
45. Kaloshi G., Benouaich-Amiel A., Diakite F., Taillibert S., Lejeune J., Laigle-Donadey F., et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007, 68:1831-1836.
46. Lebrun C., Fontaine D., Bourg V., Ramaioli A., Chanalet S., Vandenbos F., et al. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol. 2007, 14:391-398.
47. Taillandier L., Duffau H. Epilepsy and insular grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases. Neurosurg Focus. 2009, 27. E8.
48. Sherman J.H., Moldovan K., Yeoh H.K., Starke R.M., Pouratian N., Shaffrey M.E., et al. Impact of temozolomide chemotherapy on seizure frequency in patients with lowgrade gliomas. J Neurosurg. 2011, 114:1617-1621.
49. Rudà R., Bertero L., Trevisan E., Pace A., Carapella C.M., Dealiset C., et al. Phase II trial of dose-dense temozolomide as initial treatment for progressive low-grade oligodendroglial tumors: a multicentric study of the Italian Association of Neuro-Oncology (AINO). [Abstract] J Clin Oncol. 2012, 30:2037.
50. Krueger D.A., Care M.M., Holland K., Agricola K., Tudor C., Mangeshkaret P., et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010, 363:1801-1811.